Adhesive formulations
View Patent ↗The disclosure relates to biocompatible components useful for forming compositions for use as medical/surgical synthetic adhesives and sealants. Biocompatible components of the present disclosure may include a polymeric polyol core, which may be treated with a nitroaryl compound to form a nitro ester. The resulting nitro ester groups may be reduced to form amino groups which, in turn, may be treated to form isocyanate groups. The resulting isocyanate may then be reacted with a second component to form adhesive and/or sealant compositions.
1. A biocompatible component of the formula:
wherein R is selected from the group consisting of alkyl groups, cycloalkyl groups, alkenyl groups, alkynyl groups, alkylene groups, cycloalkylene groups, alkenylene groups, alkynylene groups, aromatic groups, heteroaromatic groups, heterocyclic groups, and combinations thereof;
n can be from 1 to 5;
R 1 can be the same or different at each location and is selected from the group consisting of OCH 2 , SCH 2 , O-alkyl, S-alkyl, O-aryl, and combinations thereof; and
PAO is a polyalkylene oxide having a molecular weight of from about 200 to about 4000.
2. The biocompatible component of claim 1 , wherein R is selected from the group consisting of methylene, ethylene, propylene, butylene, cyclohexylene, phenylene, pyridylene, and combinations thereof.
3. The biocompatible component of claim 1 , wherein the polyalkylene oxide is selected from the group consisting of polyethylene glycols, polypropylene glycols, polyethylene oxides, polypropylene oxides, polyethylene glycols with lactide linkages, polypropylene glycol-co-polyethylene oxide copolymers, polyethylene oxide/polypropylene oxide copolymers, and combinations thereof.
4. A composition comprising the biocompatible component of claim 1 in combination with a second component.
5. The composition of claim 4 , wherein the second component comprises a polyol.
6. The composition of claim 5 , wherein the polyol is selected from the group consisting of glycerol, trimethylol propane, hexane-1,2,6-triol, polycaprolactone triol, polyalkylene oxides, and combinations thereof.
7. The composition of claim 4 , wherein the biocompatible component of claim 1 is present in an amount from about 50 to about 90 percent by weight of the composition, and the second component is present in an amount from about 10 to about 50 percent by weight of the composition.
8. A method for closing a wound comprising:
applying the composition of claim 4 to said wound; and
allowing the composition to set thereby closing said wound.
9. A method for sealing a leak in animal tissue comprising:
applying the composition of claim 4 to said leak; and
allowing the composition to set thereby sealing said leak.
10. A method for adhering a medical device to a surface of animal tissue comprising:
applying the composition of claim 4 to said device, said surface or both;
bringing the device, composition and surface into contact with each other; and
allowing the composition to set thereby adhering the device and surface to each other.